methotrexate has been researched along with Menopause in 204 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 142 (69.61) | 18.7374 |
| 1990's | 39 (19.12) | 18.2507 |
| 2000's | 15 (7.35) | 29.6817 |
| 2010's | 8 (3.92) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wei, XY; Yu, XL | 1 |
| Orr, A; Parker, R | 1 |
| Chen, ML; Jeng, C; Lin, YC; Liu, LN; Miaskowski, C; Wang, JS; Wen, FH | 1 |
| Abdel-Fatah, TM; Ball, GR; Chan, SY; Ellis, IO; Johnson, C; McArdle, SE; Moseley, PM; Pockley, AG; Rees, RC | 1 |
| Hoek, A; Sanders, JS; Stegeman, CA; Tuin, J; van Beek, AP | 1 |
| Brown, RW; Castiglione-Gertsch, M; Coates, AS; Colleoni, M; Crivellari, D; Gelber, RD; Giobbie-Hurder, A; Goldhirsch, A; Golouh, R; Gusterson, BA; Karlsson, P; Maiorano, E; Mallon, E; Mastropasqua, MG; Öhlschlegel, C; Price, KN; Regan, MM; Sonzogni, A; Viale, G | 1 |
| Castiglione-Gertsch, M; Chua, BH; Cole, BF; Colleoni, M; Goldhirsch, A; Gruber, G; Karlsson, P; Murray, E; Price, KN; Roncadin, M | 1 |
| Bighin, C; Boni, L; Cresti, N; Del Mastro, L; Gamucci, T; Garrone, O; Giordano, M; Giraudi, S; Gori, S; Levaggi, A; Magnolfi, E; Michelotti, A; Olmeo, N; Pronzato, P; Scotto, T; Vecchio, C; Venturini, M | 1 |
| Bella, M; Bisagni, G; Boni, C; Bruzzi, P; Camisa, R; Ceci, G; Cocconi, G; Di Blasio, B; Leonardi, F; Rondini, E; Savoldi, L | 1 |
| Banzi, MC; Bertolini, M; Bondi, M; Del Rio, G; Federico, M; Menozzi, R; Piccinini, L; Valeriani, L; Zironi, S | 1 |
| Athens, JW; Costanzi, JJ; Green, SJ; Lew, D; Martino, S; Osborne, CK; Rivkin, SE; Vaughn, CB | 1 |
| Bertsch, H; Fox, K; Glick, J; Harris, EE; Schultz, D; Solin, LJ | 1 |
| Anderson, S; Fisher, B; Jeong, JH; Wolmark, N | 1 |
| Dodd, M; Dowling, G; Jansen, C; Kramer, J; Miaskowski, C | 1 |
| Arai, K; Endo, N; Fujisawa, J; Hanyu, T; Kondo, N; Murai, T; Nakazono, K; Sugitani, H | 1 |
| Briot, K | 1 |
| Castiglione-Gertsch, M; Gelber, RD; Gelber, S; Goldhirsch, A; Partridge, A; Winer, E | 1 |
| Gallucci, B; Schwartz, AL; Winters-Stone, K | 1 |
| Saito, E; Suwa, A; Suzuki, Y; Wakabayashi, T | 1 |
| Anton-Culver, H; Begg, CB; Bernstein, JL; Bernstein, L; Bertelsen, L; Boice, JD; Capanu, M; Christensen, J; Ejlertsen, B; Haile, RW; Langholz, B; Lynch, CF; Malone, KE; Mellemkjaer, L; Olsen, JH; Shore, RE; Stovall, M; Thomas, DC | 1 |
| Braye, S; Brown, RW; Castiglione-Gertsch, M; Coates, AS; Gelber, RD; Goldhirsch, A; Golouh, R; Grigolato, P; Gusterson, BA; Kovács, A; Maiorano, E; Mastropasqua, MG; Ohlschlegel, C; Perin, T; Pillay, K; Price, KN; Regan, MM; Rusca, T; Viale, G | 1 |
| Bonadonna, G; Rossi, A; Tancini, G; Valagussa, P | 1 |
| Berlie, J; Cappelaere, JP; Clavel, B; Guerin, J; Klein, T; Pommatau, E | 1 |
| Andersen, KW; Brincker, H; Mouridsen, HT | 1 |
| Carbone, PP | 1 |
| Wood, WC | 1 |
| Athens, JW; Costanzi, JJ; Foulkes, MA; Glucksberg, H; Knight, WA; O'Bryan, RM; Rivkin, SE; Stephens, RL | 1 |
| Bartolucci, A; Ketcham, A; Liu, C; Marcial, V; Moore, M; Smalley, R; Velez-Garcia, E; Vogel, CL | 1 |
| Jungi, WF | 1 |
| Arafah, B; Crowe, JP; Gordon, NH; Guyton, SP; Hubay, CA | 1 |
| Mouridsen, HT; Palshof, T | 1 |
| Gelber, RD | 1 |
| Tormey, C | 1 |
| Foulkes, M; Glucksberg, H; Rivkin, SE | 1 |
| Bonadonna, G; Brambilla, C; Rossi, A; Valagussa, P | 2 |
| Baral, E; Beling, U; Carstensen, J; Friberg, S; Glas, U; Kaigas, M; Skoog, L; Wallgren, A | 1 |
| Bezwoda, WR; Browde, S; Derman, DP; Goss, G; Lange, M | 1 |
| Bonadonna, G; Brambilla, C; Di Fronzo, G; Marchini, S; Rossi, A; Tancini, G; Valagussa, P | 1 |
| Lenzhofer, R; Rainer, H | 1 |
| Goldhirsch, A | 2 |
| Bonadonna, G; Rossi, A; Tancini, G; Valagussa, P; Veronesi, U | 1 |
| Arévalo, E; Leone, BA; Rabinovich, MG; Strauss, E | 1 |
| Larrad Jiménez, A; López Lazareno, N; Ruiz-Tartas, A; Zapatero Gaviria, J | 1 |
| Alberto, P; Brunner, KW; Cavalli, F; Goldhirsch, A; Jungi, WF; Martz, G; Mermillod, B; Pedrazzini, A | 1 |
| Currie, VE; Dnistrian, AM; Fracchia, AA; Hakes, TB; Kaufman, RJ; Schwartz, MK | 1 |
| Lee, YT | 1 |
| Hirshaut, Y; Kesselheim, H | 1 |
| Biran, S; Brufman, G; Fuks, Z; Rizel, S; Sulkes, A; Weshler, Z | 1 |
| Bian, AR; De Luca, L; Englaro, E; Englaro, GC; Geatti, O; Marsilio, P; Nadalin, L | 1 |
| Brodovsky, H; Catalano, RB; Creech, RH; Glick, JH; Holroyde, C; Torri, S; Varano, M | 2 |
| Senn, HJ | 1 |
| Boesen, E; Mouridsen, HT | 1 |
| Mobbs, BG | 1 |
| Carter, SK | 3 |
| Cooper, MR; Ferree, C; Howard, V; Jackson, DV; Muss, HB; Rhyne, AL; Richards, F; Shore, A; Spurr, CL; Stuart, JJ; White, DR | 1 |
| Egger, H; Gunselmann, W; von Maillot, K | 1 |
| Levitt, SH; Potish, RA | 1 |
| Engelsman, E; Heuson, JC; Sylvester, R | 1 |
| Engelsman, E; Mouridsen, HT; Palshof, T; Sylvester, R | 1 |
| Bajetta, E; Banfi, A; Bonadonna, G; Brambilla, C; Marchini, S; Rossi, A; Tancini, G; Tesoro Tess, JD; Valagussa, P; Veronesi, U | 1 |
| Amgwerd, R; Ammann, J; Bigler, R; Creux, G; Enderlin, F; Engelhart, G; Heinz, C; Hochuli, R; Jungi, WF; Lanz, R; Seiler, S; Senn, HJ; Simon, B; Wick, A | 1 |
| Bickers, J; Costanzi, J; el Mawli, NG; Heilburn, L; Hoogstraten, B; Maloney, T; McDonald, B; Palmer, R; Rasmusen, S; Thigpen, T; Tranum, BL; Vaughn, C; Wilson, H | 1 |
| Canellos, GP; Hellman, S; Veronesi, U | 1 |
| Athens, J; Costanzi, J; Gad-el-Mawla, N; Glucksberg, H; Hoogstraten, B; Maloney, T; McCracken, J; Rasmussen, S; Rivkin, SE; Tranum, B; Vaughn, C | 1 |
| Alberto, P; Beer, M; Brunner, KW; Cavalli, F; Jungi, WF; Martz, G; Mermillod, B; Obrecht, JP | 1 |
| Agarwal, M; Hanson, J; Lees, A; Paterson, AH; Szafran, O | 1 |
| Kalman, AM; Thompson, T; Vogel, CL | 1 |
| Brunner, KW; Goldhirsch, A; Joss, R; Sonntag, RW; Tschopp, L | 1 |
| Bateman, JR; Chlebowski, RT; Godfrey, T; Hestorff, R; Lang, JE; Luce, J; Reynolds, R; Ryden, VM; Weiner, JM | 1 |
| Kreienberg, R; Melchert, F; von Nathusius, U | 1 |
| Queisser, W | 1 |
| Bonadonna, G; Valagussa, P | 2 |
| Eaton, M; Humeniuk, V; Kent, AL; Marshall, N | 1 |
| Berger, A; Budinsky, AC; Eibl, M; Krainer, M; Kubista, E; Müller, C; Speiser, P; Wiltschke, C; Zeillinger, R; Zielinski, CC | 1 |
| Bentley, AE; Houston, SJ; Richards, MA; Rubens, RD; Smith, P | 1 |
| Bari, M; Bruscagnin, G; Gatti, C; Gion, M; Leon, AE; Mione, R; Nascimben, O; Pappagallo, GL; Vinante, O | 1 |
| Bhardwaj, S; Holland, JF; Norton, L | 1 |
| Bajetta, E; Bichisao, E; Buzzoni, R; Celio, L; Noberasco, C; Zilembo, N | 1 |
| Powles, TJ; Smith, IE | 1 |
| Bertelli, G; Bruzzi, P; Del Mastro, L; Garrone, O; Guelfi, M; Pastorino, S; Rosso, R; Sertoli, MR; Venturini, M | 1 |
| Antonelli, G; Bonadonna, G; De Candis, D; Valagussa, P | 1 |
| Bünemann, H; Heilmann, HP; Janik, I; Willers, H; Würschmidt, F | 1 |
| Castiglione, M; Cavalli, F; Jungi, WF; Leyvraz, S; Maibach, R; Obrecht, JP; Schildknecht, O; Senn, HJ; Siegenthaler, P | 1 |
| Mizushima, Y; Suzuki, Y | 1 |
| Barbareschi, M; Bevilacqua, P; Boracchi, P; Caffo, O; Doglioni, C; Gasparini, G; Mauri, FA; Morelli, L; Palma, PD; Verderio, P | 1 |
| Barnes, DM; Gillett, CE; Harris, WH; Miles, DW; Smith, P | 1 |
| Graeff, H; Harbeck, N; Jänicke, F; Meisner, C; Prechtl, A; Schmitt, M; Selbmann, HK; Sweep, CG; Thomssen, C; Untch, M | 1 |
| Bastert, G; Beyerle, C; Bonetti, M; Castiglione-Gertsch, M; Coates, AS; Colleoni, M; Collins, J; Crivellari, D; Gelber, RD; Goldhirsch, A; Holmberg, SB; Lindtner, J; Litman, HJ; Neumann, RL; Rudenstam, CM; Sauerbrei, W; Schmoor, C; Schumacher, M; Thürlimann, B | 1 |
| Davis, TE; Rose, DP | 1 |
| Canavese, JC | 1 |
| Byron, RL; Jacobs, W; Keating, J; Riihimaki, DU; Tan, MS; Yonemoto, RH | 1 |
| Banfi, A; Bonadonna, G; Rossi, A; Valagussa, P; Veronesi, U | 1 |
| Alberto, P; Brunner, KW; Martz, G; Maurice, P; Obrecht, P; Senn, HJ; Sonntag, RW | 1 |
| Amgwerd, R; Bigler, R; Creux, G; Enderlin, F; Engelhart, G; Heinz, C; Hochueli, R; Jungi, WF; Lanz, R; Senn, HJ; Simeon, B; Sprenger, F; Wick, A | 1 |
| Drings, P; Kaufmann, M; Kubli, F; Lammers, G | 1 |
| Borisov, AI | 1 |
| Engelsman, E; Hamersma, E; Schaake, C | 1 |
| Blumenschein, GR; Buzdar, AV; Gehan, EA; Gutterman, JU; Hersh, EM; Hortobágyi, GN; Tashima, CK; Yap, HY | 1 |
| Mason, B; Stephens, EJ; Wood, HF | 1 |
| Berstock, DA; Houghton, J; Kearney, G; Leiberman, DP | 1 |
| Arwidi, A; Lindholm, CE; Mattsson, W; von Eyben, F | 1 |
| Fisher, B | 1 |
| Carey, RW; Halpern, E; Kaufman, S; Kelley, RM; Lew, RA; Sohier, WD; Weitzman, SA | 1 |
| Geiger, W; Künzig, HJ; Schmidt-Rhode, P; Schulz, KD; Weymar, P | 1 |
| Holland, JF | 1 |
| Heuson, JC | 1 |
| Grillo-López, A; Lozada, JA; Vélez-Garciá, E | 1 |
| Armentrout, SA; Otis, PT | 1 |
| Addamo, GF; Coialbu, T; Costantini, M; Giacchero, A; Guido, T; Repetto, L; Rosso, R; Toma, S | 1 |
| Balar, DB; Bhatavdekar, JM; Ghosh, N; Giri, DD; Karelia, NH; Patel, DD; Shah, NG; Trivedi, SN; Vora, HH | 1 |
| Amoroso, D; Boccardo, F; Castagnetta, L; Farris, A; Genta, F; Nenci, I; Piffanelli, A; Rubagotti, A; Sismondi, P; Traina, A | 1 |
| Cooper, MR; Eudey, L; Falkson, G; Gilchrist, KW; Mansour, EG; Osborne, CK; Shatila, AH; Tormey, DC | 1 |
| Labadini, A; Pandolfi, C; Sbalzarini, G | 1 |
| Andreola, S; Baldini, MT; Bufalino, R; Cascinelli, N; Galluzzo, D; Greco, M; Leo, E; Morabito, A; Rilke, F; Testori, A | 1 |
| Buscema, J; Currie, JL; McLellan, R; Woodruff, JD | 1 |
| Luboinski, G; Nagadowska, M; Pienkowski, T | 1 |
| Berlie, J; De Gislain, C; Delozier, T; Denis, V; Julien, JP; Lacour, J; Laplanche, A; Mourali, N; Namer, M; Petit, JC | 1 |
| Devi, CS; Marar, T; Subramaniam, S | 1 |
| Hartmann, LC; Ingle, JN; Marschke, RF; Schaid, DJ | 1 |
| Bethune, WA | 1 |
| Bonadonna, G; Buzzoni, R; Valagussa, P; Zambetti, M | 1 |
| Aiginger, P; Czerwenka, K; Kubista, E; Mikl, J; Salzer, H; Sevelda, P; Spona, J; Staffen, A; Zielinski, CC | 1 |
| Castiglione, M; Gelber, RD; Goldhirsch, A | 2 |
| Ashley, S; Jodrell, DI; Mansi, JL; McKinna, JA; Pearson, MC; Sinnett, HD; Smith, IE; Walsh, G | 1 |
| Krishnamurthi, S; Shanta, V | 1 |
| Camplejohn, RS; Millis, RR; O'Reilly, SM; Richards, MA; Rubens, RD | 1 |
| Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH | 1 |
| Boccardo, F; Bruzzi, P; Cappellini, M; Isola, G; Nenci, I; Piffanelli, A; Rubagotti, A; Santi, L; Scanni, A; Sismondi, P | 1 |
| Currie, V; Geller, NL; Hakes, TB; Kaufman, R; Petroni, GR | 1 |
| Chaudary, MA; Crowther, D; Fentiman, IS; George, WD; Howell, A; O'Reilly, SM; Richards, MA; Rubens, RD | 1 |
| Bartoli, C; Bonadonna, G; Brambilla, C; Coopmans de Yoldi, G; Ferrari, L; Greco, M; Luini, A; Rilke, F; Veronesi, U; Zucali, R | 1 |
| Carbone, PP; Cummings, FJ; Gilchrist, K; Grage, T; Gray, R; Tormey, DC; Woll, JE; Wolter, J | 1 |
| Becher, R; Höfeler, H; Kloke, O; Kurschel, E; Schilcher, RB; Schmidt, CG; Wandl, U; Weinhardt, O | 1 |
| Bonadonna, G; Valagussa, P; Zambetti, M | 1 |
| Mouridsen, HT | 2 |
| Tormey, DC | 1 |
| Carbone, PP; Cummings, FJ; Falkson, G; Gilchrist, KW; Knuiman, MW; Olson, JE; Rosenthal, SN; Sleeper, LA; Taylor, SG; Tormey, DC | 1 |
| Bezwoda, WR; Browde, S; Dansey, R; De Moor, NG; Derman, DP; Kessel, IL; Lange, M; Seymour, L | 1 |
| Bonadonna, G; Brambilla, C; Valagussa, P; Zambetti, M | 1 |
| Stewart, HJ | 1 |
| Abel, U; Jonat, W; Kaufmann, M | 2 |
| Gelber, RD; Goldhirsch, A | 2 |
| Blijham, G; Dittrich, D; Jakesz, R; Rainer, H; Reiner, A; Reiner, G; Reynders, M; Schemper, M; Schutte, B; Spona, J | 1 |
| Arafah, BM; Crowe, JP; Gordon, NH; Hubay, CA; Marshall, JS; McGuire, W; Pearson, OH | 1 |
| Howell, A; Padmanabhan, N; Rubens, RD | 1 |
| Bianco, AR; D'Istria, M; De Placido, S; Delrio, G; Gallo, C; Marinelli, A; Pagliarulo, C; Petrella, G | 1 |
| Cooper, MR; Falkson, G; Gilchrist, KW; Gray, R; Mansour, EG; Osborne, CK; Shatila, AH; Tormey, DC | 1 |
| Camaggi, CM; Cilenti, G; Fruet, F; Martoni, A; Pannuti, F | 1 |
| Carruba, G; Castagnetta, L; Ciaccio, M; Di Carlo, A; Polito, L; Traina, A | 1 |
| Cassidy, J; Lippman, ME; Wesley, M; Young, RC | 1 |
| Andersen, J; Andersen, KW; Axelsson, CK; Brincker, H; Dombernowsky, P; Hansen, M; Mouridsen, HT; Overgaard, M; Panduro, J; Rose, C | 1 |
| Hrafnkelsson, J; Nilsson, K; Söderberg, M | 1 |
| Buzdar, AU; Fraschini, G; Holmes, FA; Hortobagyi, GN; Hug, V; Jabboury, K; Kau, SW; Theriault, RL | 1 |
| Alavaikko, M; Blanco, G; Hietanen, T; Kallioniemi, OP; Koivula, T; Lauslahti, K; Lehtinen, M; Mattila, J | 1 |
| Andersen, KW; Brincker, H; Dombernowsky, P; Jakobsen, A; Mouridsen, HT; Panduro, J; Rank, F; Rose, C | 1 |
| Ahmann, FR; Jones, SE; Moon, TE | 1 |
| Beex, LV; Benraad, TJ; Kloppenborg, PW; Mackenzie, MA; Raemaekers, JM; Smals, AG | 1 |
| Andersson, M; Mouridsen, HT | 1 |
| Belpomme, D; Delgado, M; Fumoleau, P; Guerrin, J; Le Mevel, B; Mathé, G; Metz, R; Misset, JL; Plagne, R; Reizenstein, P | 1 |
| Hryniuk, W; Levine, MN | 1 |
| Ivanova, OA; Moiseenko, VM; Semiglazov, VF | 1 |
| Lippman, ME; Swain, SM | 1 |
| Moore, JW; Padmanabhan, N; Rubens, RD; Wang, DY | 1 |
| Citarella, F; Contegiacomo, A; d'Istria, M; De Placido, S; De Sio, L; Delrio, G; Fasano, S; Iaffaioli, RV; Marinelli, A; Pagliarulo, C | 1 |
| Falkson, G; Gelman, RS; Pretorius, FJ | 1 |
| Cohen, SC; Gregory, EJ; Mims, CH; Oines, DW | 1 |
| Dillon, HJ; Dnistrian, AM; Fracchia, AA; Greenberg, EJ; Hakes, TB; Schwartz, MK | 1 |
| Bonadonna, G; Brambilla, C; Rossi, A; Tancini, G; Valagussa, P; Veronesi, U; Zambetti, M | 1 |
| Bianco, AR; D'Istria, M; De Placido, S; De Sio, L; Delrio, G; Fasano, S; Pagliarulo, C; Ricciardi, I | 1 |
| Engelsman, E; Hart, G; Schaake-Koning, C; van der Linden, EH | 1 |
| Rosso, R; Scarsi, PG; Sertoli, MR | 1 |
| Henderson, IC | 1 |
| Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC | 1 |
| Durrant, KR; Giraud-Saunders, AM; Gough, MH; McPherson, K; Paine, CH; Vessey, MP | 1 |
| Engelsman, E; Mouridsen, HT; Rose, C; Rotmensz, N; Sylvester, R | 1 |
| Alonso, MC; Avella, A; Beltrán, M; Borrás, J; Bosch, FX; Ojeda, B; Viladiu, P | 1 |
| Boccardo, F; Rosso, R; Rubagotti, A; Santi, L | 1 |
| Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, R | 1 |
| Engelsmann, E; Mouridsen, HT; Rose, C; Rotmensz, N; Sylvester, R | 1 |
| Gordon, NH; Hubay, CA; Manni, A; McGuire, WL; Pearson, OH | 1 |
| Baral, E; Glas, U; Karnström, L; Nordenskiöld, B; Silfverswärd, C; Theve, NO; Wallgren, A | 1 |
| Andersson, M; Mouridsen, HT; Pedersen, L | 1 |
| Bachenheimer, L; Beiser, C; Byrne, P; Dritschilo, A; Goldberg, R; Smith, F; Smith, L; Stefanik, D; Ueno, W | 1 |
| Goncharova, MG; Murav'eva, NI; Sharoukhova, KS; Smirnova, KD; Sokolova, VD | 1 |
| Abeloff, MD; Baker, RR; Lee, JM; Lenhard, RE | 1 |
| Canellos, GP; Chabner, BA; Devita, VT; Gold, GL; Schein, PS; Young, RC | 1 |
| Perevodchikova, NI; Sokolova, VD | 1 |
17 review(s) available for methotrexate and Menopause
| Article | Year |
|---|---|
Ten-year outcome after combined modality therapy for inflammatory breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Life Tables; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pennsylvania; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome | 2003 |
Potential mechanisms for chemotherapy-induced impairments in cognitive function.
Topics: Anemia; Animals; Antineoplastic Agents; Attention; Blood-Brain Barrier; Cognition Disorders; Cyclophosphamide; Doxorubicin; Encephalitis; Fluorouracil; Humans; Inflammation; Language; Learning; Memory; Menopause; Methotrexate; Neoplasms; Oncology Nursing; Paclitaxel; Psychomotor Performance; Spatial Behavior | 2005 |
[Non-corticosteroid drug-induced metabolic bone disease].
Topics: Aged; Animals; Anticoagulants; Anticonvulsants; Antipsychotic Agents; Aromatase Inhibitors; Bone Density; Child; Cyclosporins; Densitometry; Disease Progression; Diuretics; Female; Follow-Up Studies; Fractures, Bone; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Iatrogenic Disease; Immunosuppressive Agents; Lithium Compounds; Male; Menopause; Methotrexate; Middle Aged; Osteomalacia; Osteoporosis; Osteoporosis, Postmenopausal; Placebos; Prospective Studies; Protease Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Tacrolimus; Thyroid Hormones; Time Factors | 2006 |
[Pathologic condition of osteoporosis in rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Bone Remodeling; Bone Resorption; Cell Differentiation; Cyclosporine; Disease Progression; Glucocorticoids; Humans; Menopause; Methotrexate; Osteoclasts; Osteoporosis; RANK Ligand; Tumor Necrosis Factor-alpha | 2007 |
[Adjuvant chemotherapy in breast cancer: status in 1984].
Topics: Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Neoplasm Recurrence, Local; Time Factors | 1984 |
Hormone receptors. An update and application.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Prednisone; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Vincristine | 1984 |
Adjuvant systemic therapy in primary breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Fluorouracil; Humans; Mastectomy; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Random Allocation; Receptors, Estrogen; Tamoxifen; Time Factors | 1984 |
The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
Topics: Axilla; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate | 1981 |
Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
Topics: Adult; Age Factors; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Professional Staff Committees; Tamoxifen; Time Factors | 1998 |
Osteoporosis in rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Animals; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Folic Acid Antagonists; Humans; Menopause; Methotrexate; Middle Aged; Movement; Osteoporosis; Rats; Sex Factors | 1997 |
[Lupus erythematosus, modern aspects (author's transl)].
Topics: Antacids; Antibodies, Antinuclear; Antigen-Antibody Complex; Azathioprine; Chlorambucil; Cyclophosphamide; Cystitis; Diabetes Mellitus; DNA; Female; Herpes Zoster; Humans; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Menopause; Methotrexate; Neutrophils; Prednisone | 1977 |
[Adjuvant (preventive) postoperative chemotherapy in breast carcinoma].
Topics: Breast Neoplasms; Chlorambucil; Cyclophosphamide; Female; Fluorouracil; Humans; Melphalan; Menopause; Methotrexate; Postoperative Care | 1978 |
Adjuvant chemotherapy for node-negative breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymph Nodes; Mastectomy; Menopause; Methotrexate; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Estrogen; Thiotepa; Vincristine | 1989 |
Controversies in the treatment of cancer of the breast.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Ovary; Prednisone | 1987 |
Adjuvant systemic therapy for resectable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Immunotherapy; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Research Design; Tamoxifen | 1985 |
Hormono-chemotherapy in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Hormones; Humans; Menopause; Methotrexate; Middle Aged; Prednisone; Random Allocation; Vincristine | 1985 |
Single and combination nonhormonal chemotherapy in breast cancer.
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Cyclophosphamide; Drug Synergism; Female; Fluorouracil; Humans; Hydroxyurea; Melphalan; Menopause; Methotrexate; Mice; Vinblastine; Vincristine | 1972 |
115 trial(s) available for methotrexate and Menopause
| Article | Year |
|---|---|
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease Progression; Female; Fluorouracil; Goserelin; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Predictive Value of Tests; Prognosis; Treatment Outcome | 2010 |
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.
Topics: Age Factors; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Mastectomy, Segmental; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Receptors, Estrogen; Regression Analysis; Tamoxifen; Time Factors | 2011 |
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Goserelin; Humans; Infertility, Female; Injections, Intramuscular; Luteolytic Agents; Menopause; Methotrexate; Middle Aged; Neoadjuvant Therapy; Premenopause; Primary Ovarian Insufficiency; Tamoxifen; Triptorelin Pamoate | 2011 |
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Logistic Models; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Multivariate Analysis; Prospective Studies; Vincristine | 2002 |
Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body composition.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Composition; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Energy Metabolism; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Patient Selection; Weight Gain | 2002 |
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Modified Radical; Mastectomy, Radical; Melphalan; Menopause; Methotrexate; Middle Aged; Prednisone; Survival Rate; Vincristine | 2003 |
Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Proportional Hazards Models; Receptors, Estrogen; Survival Analysis; Treatment Outcome | 2004 |
Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Proportional Hazards Models | 2007 |
Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy.
Topics: Antineoplastic Agents; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Exercise Therapy; Female; Glucocorticoids; Humans; Menopause; Methotrexate; Middle Aged; Osteoporosis; Prospective Studies | 2007 |
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Goserelin; Humans; Immunohistochemistry; Menopause; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Predictive Value of Tests; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome | 2008 |
Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prednisone; Random Allocation; Tamoxifen | 1984 |
[Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
Topics: Androstanols; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Random Allocation; Receptors, Estrogen; Tamoxifen | 1982 |
Adjuvant chemotherapy with cyclophosphamide or CMF in premenopausal women with stage II breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymph Node Excision; Mastectomy; Menopause; Methotrexate; Middle Aged; Postoperative Period; Prospective Studies; Random Allocation | 1983 |
Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Prednisone; Tamoxifen | 1983 |
Cancer and Leukemia Group B adjuvant chemotherapy trials in postmastectomy breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Prednisone; Vincristine | 1983 |
Adjuvant therapy of breast cancer: the Southwest Oncology Group experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Prednisone; Vincristine | 1983 |
Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: the Southeastern Cancer Study Group experience.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate | 1983 |
Adjuvant systemic therapy in primary breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Fluorouracil; Humans; Mastectomy; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Random Allocation; Receptors, Estrogen; Tamoxifen; Time Factors | 1984 |
Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prednisone; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |
Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Prednisone; Prognosis; Tamoxifen; Vincristine | 1984 |
Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Vincristine | 1984 |
Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prednisone; Prognosis; Tamoxifen; Vincristine | 1984 |
Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prognosis; Radiotherapy Dosage; Receptors, Estrogen; Tamoxifen | 1984 |
Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Chlorambucil; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Prednisone; Random Allocation; Tamoxifen; Vincristine | 1983 |
Randomized clinical trial of tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal women with advanced breast cancer.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Random Allocation; Receptors, Estrogen; Tamoxifen | 1981 |
Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trial.
Topics: Antineoplastic Agents; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Remission, Spontaneous; Tamoxifen | 1980 |
Adjuvant chemotherapy of breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy; Melphalan; Menopause; Methotrexate | 1981 |
A randomized comparative trial of chemotherapy and irradiation therapy for stage II breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Prospective Studies; Radiotherapy Dosage; Random Allocation | 1981 |
[The results of 5 years of ancillary chemotherapy of carcinoma of the breast (author's transl)].
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Postoperative Care; Vinblastine | 1981 |
The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
Topics: Axilla; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate | 1981 |
Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Tamoxifen; Vincristine | 1980 |
CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Random Allocation; Tamoxifen | 1980 |
Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.
Topics: Aged; Amenorrhea; Axilla; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prognosis | 1981 |
Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer - intermediate report at 4 years.
Topics: Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Immunotherapy; Lymphatic Metastasis; Menopause; Methotrexate; Mycobacterium bovis | 1982 |
Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Prednisone; Random Allocation; Vincristine | 1982 |
Occasional notes. The management of early breast cancer.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Estrogen Antagonists; Female; Fluorouracil; Humans; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis | 1982 |
Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study.
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Prednisone; Vincristine | 1982 |
[Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Castration; Chlorambucil; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Tamoxifen; Vincristine | 1982 |
Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group Project.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Random Allocation | 1981 |
The influence of adjuvant chemotherapy on outcome after relapse for patients with breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Tamoxifen; Time Factors; Treatment Outcome | 1993 |
An intensive sequenced adjuvant chemotherapy regimen for breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Prednisone; Vincristine | 1993 |
MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Melphalan; Menopause; Methotrexate; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Staging; Vincristine | 1993 |
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer.
Topics: Adult; Aged; Analysis of Variance; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Diethylstilbestrol; Disease Progression; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged | 1996 |
Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Chlorambucil; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Switzerland; Treatment Outcome | 1997 |
Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Predictive Value of Tests; Receptor, ErbB-2; Receptors, Estrogen; Regression Analysis; Survival Rate; Time Factors | 1999 |
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Nodes; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Predictive Value of Tests; Prognosis; Risk Factors; Time Factors; Treatment Outcome; Urokinase-Type Plasminogen Activator | 2001 |
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Premenopause; Survival Rate; Time Factors | 2002 |
Randomized sequential hormonal therapy vs adrenalectomy for metastatic breast carcinoma.
Topics: Adrenalectomy; Adult; Breast Neoplasms; Castration; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Time Factors | 1977 |
The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.
Topics: Amenorrhea; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Thrombocytopenia | 1977 |
Combined chemo- and hormonal therapy in advanced breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Castration; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Medroxyprogesterone; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Vincristine | 1977 |
Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients. Intermediate report of a randomized trial in 242 patients.
Topics: Administration, Oral; Aged; BCG Vaccine; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Neoplasm Recurrence, Local | 1978 |
[Combined drug treatment of far-advanced forms of breast cancer].
Topics: Antineoplastic Agents; Breast Neoplasms; Castration; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Hexestrol; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Neoplasm Metastasis; Prednisolone; Testosterone; Time Factors; Vincristine | 1978 |
Pilot study on adjuvant chemotherapy and hormonal therapy for irradiated inoperable breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Pilot Projects; Tamoxifen; Vincristine | 1978 |
Adjuvant therapy of stage II, III breast cancer.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Neoplasm Staging | 1978 |
Levamisole: as adjuvant to cyclic chemotherapy in breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis | 1978 |
Oral adjuvant therapy in breast carcinoma--a multicentre trial.
Topics: Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Melphalan; Menopause; Methotrexate; Vomiting | 1979 |
Combination chemotherapy in advanced postmenopausal mammary carcinoma. A comparison between VAC and VACM therapy.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leucovorin; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Random Allocation; Vincristine | 1979 |
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Proteins; Receptors, Estrogen; Tamoxifen | 1992 |
Chemotherapy versus observation in high-risk node-negative breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Neoplasm Recurrence, Local; Postoperative Care; Prednisone; Receptors, Estrogen; Risk Factors; Survival Rate | 1992 |
Polyadenylic-polyuridylic acid plus locoregional and pelvic radiotherapy versus chemotherapy with CMF as adjuvants in operable breast cancer. A 6 1/2 year follow-up analysis of a randomized trial of the French Federation of Cancer Centers (F.F.C.C.).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Pelvis; Poly A-U; Prospective Studies; Survival Rate | 1991 |
Systemic adjuvant therapy in women with resected node-negative breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Receptors, Estrogen; Tamoxifen; Time Factors | 1991 |
Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Heart Failure; Humans; Infusions, Intravenous; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Survival Analysis | 1991 |
Adjuvant tamoxifen in postmenopausal stage II breast cancer five years on.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Menopause; Methotrexate; Neoplasm Staging; Prospective Studies; Randomized Controlled Trials as Topic; Tamoxifen | 1990 |
Adjuvant chemo-endocrine therapy in postmenopausal women with breast cancer and axillary-node metastases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Evaluation Studies as Topic; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Prednisone; Randomized Controlled Trials as Topic; Tamoxifen | 1990 |
A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone; Neoplasm Staging | 1991 |
Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cyclophosphamide; DNA, Neoplasm; Female; Flow Cytometry; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Menopause; Methotrexate; Prognosis; S Phase | 1990 |
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Survival Analysis; Tamoxifen | 1990 |
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Italy; Lymph Nodes; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Prospective Studies; Random Allocation; Receptors, Estrogen; Tamoxifen | 1990 |
Association of disease-free survival and percent of ideal dose in adjuvant breast chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Levamisole; Menopause; Methotrexate; Retrospective Studies; Survival Analysis | 1990 |
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy, Modified Radical; Menopause; Menstrual Cycle; Methotrexate; Middle Aged; Survival Rate | 1990 |
Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Prevalence; Prognosis; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen | 1990 |
Adjuvant chemotherapy for node-negative breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymph Nodes; Mastectomy; Menopause; Methotrexate; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Estrogen; Thiotepa; Vincristine | 1989 |
How to improve adjuvant treatment results in postmenopausal patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Meta-Analysis as Topic; Methotrexate; Middle Aged; Prednisone; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Tamoxifen; Vincristine | 1989 |
Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Random Allocation; Receptors, Estrogen | 1989 |
Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Prednisone; Random Allocation; Receptors, Estrogen; Tamoxifen | 1989 |
Adjuvant chemotherapy (CMF) for stage III breast cancer: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy; Menopause; Methotrexate; Middle Aged; Prognosis; Random Allocation | 1989 |
The Milan experience with adjuvant chemotherapy in premenopausal breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Italy; Menopause; Methotrexate; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate | 1989 |
Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Ovariectomy; Prednisone; Randomized Controlled Trials as Topic; Scotland; Survival Rate; Tamoxifen | 1989 |
Adjuvant chemo- and endocrine therapy alone or in combination in premenopausal patients (GABG Trial 1).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Tamoxifen | 1989 |
Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Multicenter Studies as Topic; Prednisone; Randomized Controlled Trials as Topic; Receptors, Estrogen; Tamoxifen | 1989 |
Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Mastectomy; Menopause; Methotrexate; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Tamoxifen | 1989 |
Significant survival benefit of node-negative breast cancer patients treated with adjuvant chemotherapy: seven-year results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aziridines; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Mastectomy; Menopause; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Survival Rate; Vincristine | 1989 |
Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy, Modified Radical; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Receptors, Estrogen; Survival Analysis; Tamoxifen; Vincristine | 1989 |
A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. The Australian and New Zealand Breast Cancer Trials Group, Clinical Oncological Society of Australia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Menopause; Methotrexate; Middle Aged; Prognosis; Random Allocation; Receptors, Estrogen; Tamoxifen; Vincristine | 1986 |
Mechanism of action of adjuvant chemotherapy in early breast cancer.
Topics: Adult; Age Factors; Aged; Amenorrhea; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Middle Aged; Postoperative Period; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Time Factors | 1986 |
Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Preoperative Care; Random Allocation; Tamoxifen | 1988 |
Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Follow-Up Studies; Humans; Italy; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Patient Compliance; Prognosis; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1988 |
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Radical; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Random Allocation; Receptors, Estrogen; Risk Factors | 1989 |
Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Methotrexate; Middle Aged; Prospective Studies; Recurrence | 1988 |
Increasing the response rate to cytotoxic chemotherapy by endocrine means.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Estrogens, Conjugated (USP); Female; Fluorouracil; Humans; Menopause; Methotrexate; Prognosis; Random Allocation; Receptors, Estrogen; Tamoxifen | 1985 |
Performance of general hospitals in delivering adjuvant chemotherapy to breast cancer patients. G.I.V.I.O. (Interdisciplinary Group for Cancer Care Evaluation), Italy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Delivery of Health Care; Female; Fluorouracil; Hospitals, General; Humans; Italy; Lymphatic Metastasis; Menopause; Methotrexate; Multicenter Studies as Topic; Prospective Studies | 1988 |
Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy, Simple; Menopause; Methotrexate; Middle Aged; Random Allocation; Risk Factors; Tamoxifen | 1988 |
Tolerance of radiotherapy combined with adjuvant chemotherapy in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Pulmonary Fibrosis; Radiotherapy, High-Energy; Random Allocation | 1987 |
Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prognosis; Prospective Studies; Receptors, Estrogen; Time Factors | 1988 |
Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Menstrual Cycle; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovariectomy; Prognosis; Prospective Studies; Random Allocation; Receptors, Estrogen; Time Factors | 1987 |
Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Random Allocation; Vincristine | 1986 |
Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymph Nodes; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Random Allocation; Statistics as Topic; Vincristine | 1986 |
[Prospective randomized study of the efficacy of adjuvant hormone therapy in patients with breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Female; Fluorouracil; Humans; Levodopa; Menopause; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Prospective Studies; Random Allocation; Tamoxifen | 1986 |
Age as a prognostic factor in recurrent breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovariectomy; Prednisone; Prognosis; Time Factors; Vincristine | 1986 |
A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Prednisone; Quality of Life; Statistics as Topic; Tamoxifen | 1986 |
Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymph Nodes; Menopause; Methotrexate; Vincristine | 1985 |
Adjuvant chemotherapy in postmenopausal women: results of sequential noncross-resistant regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Random Allocation; Vincristine | 1985 |
Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Male; Melphalan; Menopause; Methotrexate; Neoplasm Metastasis; Prednisone; Random Allocation; Vincristine | 1985 |
Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Prednisone; Prognosis; Tamoxifen; Vincristine | 1985 |
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Fluorouracil; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Obesity; Prednisone; Prognosis; Random Allocation; Receptors, Estrogen; Risk; Tamoxifen | 1985 |
Adjuvant systemic therapy for resectable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Immunotherapy; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Research Design; Tamoxifen | 1985 |
A randomized controlled trial of prophylactic cytotoxic chemotherapy in potentially curable breast cancer.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Fluorouracil; Humans; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Patient Compliance; Random Allocation | 1985 |
Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized study of CMF vs CMF plus tamoxifen.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Random Allocation; Tamoxifen | 1985 |
Chemotherapy versus chemotherapy plus hormonotherapy in postmenopausal advanced breast cancer patients. A randomized trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Medroxyprogesterone; Menopause; Methotrexate; Middle Aged; Prognosis; Random Allocation; Tamoxifen; Vincristine | 1985 |
Chemotherapy with or without tamoxifen in postmenopausal patients with late breast cancer. A randomized study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Prospective Studies; Random Allocation; Tamoxifen; Time Factors; Vincristine | 1985 |
Hormono-chemotherapy in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Hormones; Humans; Menopause; Methotrexate; Middle Aged; Prednisone; Random Allocation; Vincristine | 1985 |
Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized EORTC study of CMF vs CMF + tamoxifen.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Random Allocation; Tamoxifen; Time Factors | 1985 |
Adjuvant endocrine therapy, cytotoxic chemotherapy and immunotherapy in stage II breast cancer: 6-year result.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Immunotherapy; Mastectomy; Menopause; Methotrexate; Random Allocation; Receptors, Estrogen; Tamoxifen; Time Factors | 1985 |
Adjuvant treatment in operable breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy; Menopause; Methotrexate; Middle Aged; Patient Compliance; Prednisone; Random Allocation; Receptors, Estrogen; Tamoxifen | 1985 |
Adjuvant tamoxifen treatment in postmenopausal patients with operable breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy; Menopause; Methotrexate; Prognosis; Random Allocation; Tamoxifen | 1985 |
77 other study(ies) available for methotrexate and Menopause
| Article | Year |
|---|---|
[Comparison of the safety of two treatment methods of cesarean scar pregnancy of typeⅡ and Ⅲ in menopause within 7 weeks].
Topics: Cesarean Section; Cicatrix; Combined Modality Therapy; Curettage; Female; Humans; Menopause; Methotrexate; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Retrospective Studies; Treatment Outcome; Ultrasonography; Uterine Artery Embolization; Uterine Hemorrhage; Uterus | 2017 |
Red clover causing symptoms suggestive of methotrexate toxicity in a patient on high-dose methotrexate.
Topics: Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Interactions; Drug Overdose; Female; Flushing; Humans; Menopause; Methotrexate; Middle Aged; Plant Extracts; Psoriasis; Trifolium; Withholding Treatment | 2013 |
Weight change trajectory in women with breast cancer receiving chemotherapy and the effect of different regimens.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Longitudinal Studies; Menopause; Methotrexate; Middle Aged; Weight Gain | 2014 |
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Cyclophosphamide; DEAD-box RNA Helicases; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymphocytes, Tumor-Infiltrating; Mastectomy; Menopause; Methotrexate; Mitotic Index; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Prognosis; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome | 2014 |
Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Case-Control Studies; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Incidence; Maintenance Chemotherapy; Menopause; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisolone; Primary Ovarian Insufficiency; Remission Induction; Retrospective Studies; Risk Factors; Rituximab; Young Adult | 2016 |
Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cross-Sectional Studies; Female; Humans; Incidence; Japan; Longitudinal Studies; Lumbar Vertebrae; Menopause; Methotrexate; Middle Aged; Osteoclasts; Osteoporosis; Postmenopause; Risk Factors; Sensitivity and Specificity; Spinal Fractures; Spine; Steroids; Time Factors | 2006 |
Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Confounding Factors, Epidemiologic; Cyclophosphamide; Doxorubicin; Estrogen Receptor Modulators; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasms, Second Primary; Ovary; Radiotherapy, Adjuvant; Research Design; Risk Assessment; Tamoxifen; Treatment Outcome | 2008 |
Adjuvant chemotherapy in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate | 1983 |
Treatment of advanced breast cancer with aminoglutethimide--response after previous tamoxifen treatment.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Fluoxymesterone; Humans; Menopause; Methotrexate; Tamoxifen; Time Factors | 1984 |
Relationship between estrogen receptors and CMF adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Prognosis; Receptors, Estrogen; Tamoxifen | 1984 |
[Cytostatic therapy in metastatic breast cancer].
Topics: Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Mitoxantrone; Prednisone; Vincristine | 1984 |
Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Hysterectomy; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |
CMF adjuvant programs at the Milan Cancer Institute.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis | 1984 |
[Sequential combination chemotherapy in metastatic cancer of the breast].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Neoplasm Metastasis | 1984 |
[Correlations between PRL and 17-beta-E in human breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Estradiol; Female; Fluorouracil; Humans; Luteal Phase; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Ovariectomy; Postoperative Period; Prognosis; Prolactin | 1984 |
Endocrine consequences of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patients.
Topics: Adrenal Glands; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Endocrine Glands; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Ovary; Pituitary Gland | 1983 |
Adjuvant chemotherapy (CMF) for breast carcinoma. Patient's compliance and total dose achieved.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leukopenia; Menopause; Methotrexate; Middle Aged; Patient Compliance | 1983 |
Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Heartburn; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Time Factors; Vincristine | 1983 |
The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma.
Topics: Actuarial Analysis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Mastectomy; Menopause; Methotrexate; Postoperative Period; Retrospective Studies | 1983 |
[Bone scintigraphy in mastectomized patients with and without chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Radionuclide Imaging; Vincristine | 1983 |
[Breast neoplasms. Progress by means of adjuvant chemotherapy?].
Topics: Age Factors; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Lymphatic Metastasis; Melphalan; Menopause; Methotrexate; Prognosis | 1980 |
Prednimustine in combination with methotrexate and 5-fluorouracil in advanced breast cancer: a phase I-II study.
Topics: Aged; Breast Neoplasms; Chlorambucil; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Prednimustine | 1983 |
Effect of time and therapy on the hormone receptor status of breast carcinomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Receptors, Estrogen; Receptors, Progesterone; Time Factors | 1982 |
Brain metastases in breast cancer patients receiving adjuvant chemotherapy.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Probability; Retrospective Studies | 1982 |
Response to oophorectomy after tamoxifen failure in a premenopausal patient.
Topics: Adult; Breast Neoplasms; Castration; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Tamoxifen | 1982 |
[Results of, and indications for adjuvant chemotherapy in breast cancer].
Topics: Adult; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Risk; Vincristine | 1981 |
[Adjuvant chemotherapy in breast neoplasms. Clinical and immunologic results].
Topics: Adult; Aged; Breast Neoplasms; Concanavalin A; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Lymphocyte Activation; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis | 1980 |
[Adjuvant chemotherapy of breast neoplasms. Review of the up-to-date results of various studies including the Heidelberg study].
Topics: Adult; Breast Neoplasms; Chlorambucil; Cyclophosphamide; Evaluation Studies as Topic; Female; Fluorouracil; Germany, West; Humans; Menopause; Methotrexate; Middle Aged; Prognosis | 1980 |
Dose-response effect of adjuvant chemotherapy in breast cancer.
Topics: Aged; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis | 1981 |
Locally advanced breast cancer: is surgery warranted following chemotherapy?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Mastectomy, Simple; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Postoperative Care; Premenopause; Radiotherapy Dosage; Retrospective Studies; Survival Rate | 1995 |
Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Humans; Longitudinal Studies; Lymphatic Metastasis; Lymphocyte Activation; Lymphocytes; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Phytohemagglutinins; Predictive Value of Tests; Prognosis; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1995 |
PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cathepsin D; Chemotherapy, Adjuvant; Cyclophosphamide; Estrogens; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Prognosis; Proteins; Radioimmunoassay; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Survival Analysis; Tamoxifen; Time Factors; Trefoil Factor-1; Tumor Suppressor Proteins | 1993 |
Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapy.
Topics: Aged; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Remission Induction; Tamoxifen; Treatment Outcome | 1993 |
VIII. Women's health perception and breast cancer: issues of fertility, hormone substitution, and cancer prevention.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fertility; Fluorouracil; Humans; Menopause; Methotrexate; Pregnancy; Retrospective Studies; Risk; Treatment Outcome | 1996 |
[Combined breast-preserving surgery, chemotherapy and radiotherapy in the treatment of breast carcinoma. Effect of the interval between surgery and the beginning of radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Radiotherapy Dosage; Retrospective Studies; Time Factors | 1997 |
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Genes, bcl-2; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins c-bcl-2; Survival Rate; Tamoxifen; Time Factors | 1995 |
Ovarian function in patients receiving adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Lymphatic Metastasis; Melphalan; Menopause; Methotrexate; Middle Aged; Ovary; Vincristine | 1977 |
United States trials of adjuvant therapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Thiotepa | 1977 |
5-drug adjuvant chemotherapy for breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1979 |
The effect of combination chemotherapy on ovarian, hypothalamic and pituitary function in patients with breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Hypothalamus; Luteinizing Hormone; Menopause; Menstruation Disturbances; Methotrexate; Middle Aged; Ovary; Pituitary Gland | 1979 |
Therapy of primary breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Lymphatic Metastasis; Melphalan; Menopause; Methotrexate; Postoperative Care; Prednisone; Vincristine | 1977 |
Current overview of EORTC clinical trials with tamoxifen.
Topics: Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Menstruation; Methotrexate; Stilbenes; Tamoxifen; Vincristine | 1976 |
Combination chemotherapy for disseminated carcinoma of the breast.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Vincristine | 1975 |
Combination chemotherapy in metastatic carcinoma of the breast. Results with a three-drug combination.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Ethylnitrosourea; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis | 1975 |
Chemotherapy-induced amenorrhea and other clinical and pathological parameters in the prognosis of breast cancer patients.
Topics: Adult; Amenorrhea; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Multivariate Analysis; Ovary; Prognosis; Retrospective Studies | 1992 |
Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifen.
Topics: Adult; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Endocrine Glands; Estradiol; Female; Fluorouracil; Gonadotropins; Humans; Menopause; Methotrexate; Middle Aged; Ovary; Pituitary Gland; Progesterone; Prolactin; Tamoxifen; Testosterone | 1992 |
[Platelet aggregation during adjuvant chemotherapy with CMF].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Papillary; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Platelet Aggregation | 1991 |
Comparison of long-term survival of 1986 consecutive patients with breast cancer treated at the National Cancer Institute of Milano, Italy (1971 to 1972 and 1977 to 1978).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Italy; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Survival Rate | 1991 |
Placental site trophoblastic tumor in a postmenopausal woman.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Menopause; Methotrexate; Middle Aged; Neoplasms; Placenta Diseases; Pregnancy; Trophoblastic Neoplasms | 1991 |
Preoperative chemotherapy in primarily inoperable cancer of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Rate; Tamoxifen; Vincristine | 1991 |
Studies on the changes in plasma lipids and lipoproteins in CMF treated breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Cholesterol; Cisplatin; Fatty Acids; Female; Fluorouracil; Humans; Lipids; Lipoproteins; Menopause; Methotrexate; Phospholipids; Triglycerides | 1991 |
Adjuvant oophorectomy versus CMF for premenopausal, node-positive, hormone receptor positive patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Ovariectomy | 1991 |
Preoperative multimodal therapy for locally advanced non-inflammatory breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy, Radical; Mastectomy, Simple; Menopause; Methotrexate; Preoperative Care; Survival Rate | 1991 |
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Recurrence | 1990 |
Ifosfamide, methotrexate, and 5-fluorouracil in advanced pretreated breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorouracil; Humans; Ifosfamide; Menopause; Mesna; Methotrexate; Middle Aged; Neoplasm Metastasis; Remission Induction; Time Factors | 1989 |
Endocrine effects of adjuvant chemotherapy in premenopausal women: suggestions for the future.
Topics: Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Meta-Analysis as Topic; Methotrexate; Tamoxifen | 1989 |
Critical review of adjuvant therapy in premenopausal patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Meta-Analysis as Topic; Methotrexate; Middle Aged; Ovariectomy | 1989 |
Modulation of oestrogen excretion profiles by adjuvant chemotherapy in pre- and postmenopausal breast cancer.
Topics: Adrenal Cortex; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromatography, High Pressure Liquid; Cyclophosphamide; Estrogens; Estrogens, Catechol; Female; Fluorouracil; Gas Chromatography-Mass Spectrometry; Humans; Menopause; Methotrexate; Middle Aged; Time Factors | 1985 |
Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen | 1988 |
Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; DNA, Neoplasm; Female; Flow Cytometry; Fluorouracil; Follow-Up Studies; Humans; Interphase; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Receptors, Estrogen; Receptors, Progesterone | 1988 |
The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Retrospective Studies; Tamoxifen; Vincristine | 1988 |
Adjuvant chemotherapy in premenopausal patients with primary breast cancer; relation to drug-induced amenorrhoea, age and the progesterone receptor status of the tumour.
Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Male; Menopause; Methotrexate; Middle Aged; Receptors, Progesterone | 1988 |
Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Mitoxantrone; Prednimustine; Tamoxifen | 1988 |
Ovarian function and adjuvant chemotherapy for early breast cancer.
Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Hormones; Humans; Menopause; Methotrexate; Middle Aged | 1987 |
Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifen.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Hypothalamo-Hypophyseal System; Mastectomy; Menopause; Methotrexate; Middle Aged; Ovarian Function Tests; Ovary; Pituitary Function Tests; Tamoxifen; Time Factors | 1986 |
Megestrol acetate therapy for advanced breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Male; Megestrol; Megestrol Acetate; Menopause; Methotrexate; Receptors, Estrogen; Receptors, Progesterone | 1985 |
Case 6-1985: progressive pneumonitis after chemotherapy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Pneumonia; Prednisone; Vincristine | 1985 |
Chemohormonal therapy and endocrine function in breast cancer patients.
Topics: Adult; Amenorrhea; Androgens; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Estrogens; Female; Fluorouracil; Hormones; Humans; Menopause; Methotrexate; Pituitary Hormones; Prednisone; Prolactin; Tamoxifen; Vincristine | 1985 |
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Leukopenia; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Receptors, Estrogen; Retrospective Studies; Tamoxifen | 1985 |
Effect of adjuvant tamoxifen and CMF on endocrine function of patients with operable breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Hormones; Humans; Menopause; Methotrexate; Middle Aged; Tamoxifen | 1985 |
Rationale for combining chemotherapy and hormonal therapy in breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diethylstilbestrol; Drug Therapy, Combination; Estrogen Antagonists; Female; Fluorouracil; Humans; Interphase; Menopause; Methotrexate; Ovariectomy; Prednisone; Tamoxifen; Vincristine | 1985 |
Combined cytotoxic and endocrine treatment of postmenopausal patients with advanced breast cancer: preliminary results of a phase II study of the combination of prednimustine, novantrone, methotrexate, 5-fluorouracil, and tamoxifen.
Topics: Adult; Aged; Alopecia; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Mitoxantrone; Prednimustine; Tamoxifen | 1986 |
Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies | 1985 |
[FSH and steroid hormone excretion in breast cancer during chemotherapy].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Breast Neoplasms; Cyclophosphamide; Estrogens; Female; Fluorouracil; Follicle Stimulating Hormone; Glucocorticoids; Humans; Menopause; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pregnanediol; Thiotepa; Time Factors; Vinblastine | 1972 |
An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Topics: Administration, Oral; Adult; Aged; Blood Cell Count; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Injections, Intravenous; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Remission, Spontaneous; Vincristine | 1974 |
Cyclical combination chemotherapy for advanced breast carcinoma.
Topics: Adrenalectomy; Adult; Alopecia; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Castration; Cyclophosphamide; Drug Combinations; Female; Fluorouracil; Humans; Liver; Liver Neoplasms; Lung Neoplasms; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Thrombocytopenia | 1974 |
[Comparative evaluation of thiphosphamide, cyclophosphane, methotrexate and 5-fluorouracil in the treatment of breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Menstruation; Methotrexate; Middle Aged; Neoplasm Metastasis; Thiotepa | 1971 |